Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Factors affecting the introduction of new vaccines to poor nations: a comparative study of the Haemophilus influenzae type B and hepatitis B vaccines.

Glatman-Freedman A, Cohen ML, Nichols KA, Porges RF, Saludes IR, Steffens K, Rodwin VG, Britt DW.

PLoS One. 2010 Nov 2;5(11):e13802. doi: 10.1371/journal.pone.0013802.

2.

Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?

Lydon P, Levine R, Makinen M, Brenzel L, Mitchell V, Milstien JB, Kamara L, Landry S.

Vaccine. 2008 Dec 2;26(51):6706-16. doi: 10.1016/j.vaccine.2008.10.015. Review.

PMID:
18952134
4.

Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experience.

Hajjeh R.

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2827-32. doi: 10.1098/rstb.2011.0046. Review.

5.

The introduction of new vaccines into developing countries II. Vaccine financing.

Mahoney RT, Ramachandran S, Xu Z.

Vaccine. 2000 Jun 1;18(24):2625-35. Review.

PMID:
10781848
6.

Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.

Kallenberg J, Mok W, Newman R, Nguyen A, Ryckman T, Saxenian H, Wilson P.

Health Aff (Millwood). 2016 Feb;35(2):250-8. doi: 10.1377/hlthaff.2015.1079.

PMID:
26858377
7.

Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.

Gargano LM, Hajjeh R, Cookson ST.

Prehosp Disaster Med. 2015 Aug;30(4):402-11. doi: 10.1017/S1049023X15004781. Epub 2015 Jun 10.

PMID:
26061190
8.

Status of New Vaccine Introduction - Worldwide, September 2016.

Loharikar A, Dumolard L, Chu S, Hyde T, Goodman T, Mantel C.

MMWR Morb Mortal Wkly Rep. 2016 Oct 21;65(41):1136-1140. doi: 10.15585/mmwr.mm6541a3.

10.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
11.

Accelerating policy decisions to adopt haemophilus influenzae type B vaccine: a global, multivariable analysis.

Shearer JC, Stack ML, Richmond MR, Bear AP, Hajjeh RA, Bishai DM.

PLoS Med. 2010 Mar 16;7(3):e1000249. doi: 10.1371/journal.pmed.1000249.

12.
13.

Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature.

Griffiths UK, Miners A.

Expert Rev Pharmacoecon Outcomes Res. 2009 Aug;9(4):333-46. doi: 10.1586/erp.09.38. Review.

PMID:
19670994
14.

Haemophilus influenzae type b conjugate vaccine use and effectiveness.

Morris SK, Moss WJ, Halsey N.

Lancet Infect Dis. 2008 Jul;8(7):435-43. doi: 10.1016/S1473-3099(08)70152-X. Review.

PMID:
18582836
15.

Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).

Le Gargasson JB, Breugelmans JG, Mibulumukini B, Da Silva A, Colombini A.

Vaccine. 2013 Apr 8;31(15):1886-91. doi: 10.1016/j.vaccine.2013.02.024. Epub 2013 Feb 24.

PMID:
23462529
16.

Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.

Griffiths UK, Korczak VS, Ayalew D, Yigzaw A.

Vaccine. 2009 Feb 25;27(9):1426-32. doi: 10.1016/j.vaccine.2008.12.037. Epub 2009 Jan 13.

PMID:
19146901
17.

Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine.

Arístegui J, Usonis V, Coovadia H, Riedemann S, Win KM, Gatchalian S, Bock HL.

Int J Infect Dis. 2003 Jun;7(2):143-51.

PMID:
12839717
18.

Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.

Griffiths UK, Clark A, Hajjeh R.

J Pediatr. 2013 Jul;163(1 Suppl):S50-S59.e9. doi: 10.1016/j.jpeds.2013.03.031.

PMID:
23773595
19.

Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.

Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M.

Vaccine. 2010 Oct 8;28(43):7123-9. doi: 10.1016/j.vaccine.2010.07.028. Epub 2010 Jul 24.

PMID:
20659515
20.

Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries--worldwide, 2004-2007.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):148-51.

Supplemental Content

Support Center